Development of silver nanoparticles decorated graphene oxide-methotrexate for targeted cancer therapy

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-FDP-034
• By: YONG, Chul Soon (Yeungnam University, Gyeongsan-Si, Korea, Republic Of)
• Co-author(s): Jae Hee Kim: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Raj Kumar Thapa: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Young-Im Lee: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Jae-Myung Lee: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Dong Shik Kim: Hanyang University, Ansan-si, Korea, Republic Of
  Han Gon Choi: Hanyang University, Ansan-si, Korea, Republic Of
  Chul Soon Yong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Jong Oh Kim: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  
• Abstract:

  Background

  Recent advances in the field of cancer treatment mostly focus on the combination therapy. Carbon based systems such as graphene oxide (GO), plasmonic nanoparticles such as silver nanoparticles (AgNPs), and the folate analog, methotrexate (MTX), have been separately studied for their potential anticancer effects.

  Purpose

  In this study, we..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login